NEW YORK, July 05, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Lipocine Inc.
(“Lipocine” or “the Company”) (NASDAQ:LPCN) between June 30,
2015 and June 28, 2016. You are hereby notified that a securities class action lawsuit has been
commenced in the USDC for the District of New Jersey. To get more information go to:
http://www.zlk.com/pslra/lipocine-inc
or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no
cost or obligation to you.
The complaint alleges that throughout the Class Period, defendants issued materially false and/or misleading
statements and/or failed to disclose that: (1) Lipocine’s filing of its New Drug Application for LPCN 1021, Lipocine’s lead product
candidate, contained deficiencies; and (2) as a result, defendant’s statements about Lipocine’s business and operations were false
and misleading and/or lacked a reasonable basis.
On June 29, 2016, Lipocine announced that the U.S. Food and Drug Administration had issued a Complete Response
Letter regarding the Company’s New Drug Application for LPCN 1021. According to the Complete Response Letter, the FDA has
identified deficiencies related to the dosing algorithm for the label and concluded the application was not ready for approval in
its present form.
If you suffered a loss in Lipocine you have until August 30, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and
Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and
have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
